During scanning of the corresponding bar code on the actual appropriate medication, the locking device would be opened, whereby. Administration of the specific syringe ‘Customizing our syringe locking working with ERP systems, can a hospital, to lead to more accurate records and eliminates additional possibilities for human error in the administration of medication via a syringe, ‘said Jacob Elhadad, CEO of Medisafe 1 Technologies.. The function allows a hospital existing barcode system to electronically record the administration of a particular medication directly to a patient’s medical file.With an ERP system would be an attending physician or nurse need only scan a patient barcode, the the specific medications and to be administered for administration.
For the prevention of urinary tract infections ‘These new study results are exciting because they show that a small dose of Cystex Liquid Cranberry Complex with Proantinox may help prevent recurrent urinary tract infections compared with women ask several glasses of pure cranberry juice that does not taste drink not very good , or ‘a half gallon cranberry juice cocktail every day with with sugar, Elizabeth Kavaler, Clinical Assistant Professor of Urology at Weill Cornell Medical College says, and author of a seat on the aisle, the Essential Guide to urinary Tract problems in Women. ‘In fact, only one tablespoon ml ml) of new Cystex Liquid Cranberry Cranberry meets the benefit of eight, eight-ounce glasses of cranberry juice and has 17 times more proanthocyanidins than cranberry tablets coli coli bacteria the most common cause the most common cause of urinary tract infections – from sticking to the layer of cells in the urinary tract.Merck & Co. And Japan Tobacco Inc. announced today into a worldwide licensing separate development and marketing of JTT-305, an oral osteoanabolic agents for the treatment of osteoporosis, a disease which results bone density and strength and reduce to increased risk of bone fractures.
Of bone fractures. And Japanese Tobacco Inc. Licensing Agreement for new Drug Candidate osteoanabolic to treat osteoporosis.